Literature DB >> 29514881

Fructose-containing caloric sweeteners as a cause of obesity and metabolic disorders.

Luc Tappy1.   

Abstract

Compared with other carbohydrates, fructose-containing caloric sweeteners (sucrose, high-fructose corn syrup, pure fructose and fructose-glucose mixtures) are characterized by: a sweet taste generally associated with a positive hedonic tone; specific intestinal fructose transporters, i.e. GLUT5; a two-step fructose metabolism, consisting of the conversion of fructose carbones into ubiquitous energy substrates in splanchnic organs where fructolytic enzymes are expressed, and secondary delivery of these substrates to extrasplanchnic tissues. Fructose is a dispensable nutrient, yet its energy can be stored very efficiently owing to a rapid induction of intestinal fructose transporters and of splanchnic fructolytic and lipogenic enzymes by dietary fructose-containing caloric sweeteners. In addition, compared with fat or other dietary carbohydrates, fructose may be favored as an energy store because it uses different intestinal absorption mechanisms and different inter-organ trafficking pathways. These specific features make fructose an advantageous energy substrate in wild animals, mainly when consumed before periods of scarcity or high energy turnover such as migrations. These properties of fructose storage are also advantageous to humans who are involved in strenuous sport activities. In subjects with low physical activity, however, these same features of fructose metabolism may have the harmful effect of favoring energy overconsumption. Furthermore, a continuous exposure to high fructose intake associated with a low energy turnover leads to a chronic overproduction of intrahepatic trioses-phosphate production, which is secondarily responsible for the development of hepatic insulin resistance, intrahepatic fat accumulation, and increased blood triglyceride concentrations. In the long term, these effects may contribute to the development of metabolic and cardiovascular diseases.
© 2018. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Carbohydrate absorption; De novo lipogenesis; Fat storage; Insulin resistance; Lactate, Sugars

Mesh:

Substances:

Year:  2018        PMID: 29514881     DOI: 10.1242/jeb.164202

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  28 in total

1.  Fructose Consumption Contributes to Hyperinsulinemia in Adolescents With Obesity Through a GLP-1-Mediated Mechanism.

Authors:  Alfonso Galderisi; Cosimo Giannini; Michelle Van Name; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 2.  Molecular aspects of fructose metabolism and metabolic disease.

Authors:  Mark A Herman; Morris J Birnbaum
Journal:  Cell Metab       Date:  2021-10-06       Impact factor: 27.287

3.  Sugar-sweetened beverage and sugar consumption and colorectal cancer incidence and mortality according to anatomic subsite.

Authors:  Chen Yuan; Hee-Kyung Joh; Qiao-Li Wang; Yin Zhang; Stephanie A Smith-Warner; Molin Wang; Mingyang Song; Yin Cao; Xuehong Zhang; Emilie S Zoltick; Jinhee Hur; Andrew T Chan; Jeffrey A Meyerhardt; Shuji Ogino; Kimmie Ng; Edward L Giovannucci; Kana Wu
Journal:  Am J Clin Nutr       Date:  2022-06-07       Impact factor: 8.472

4.  Chrysin ameliorates nonalcoholic fatty liver disease in rats.

Authors:  Sarayu A Pai; Renuka P Munshi; Falguni H Panchal; Ila-Shruti Gaur; Archana R Juvekar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-01       Impact factor: 3.000

Review 5.  Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism.

Authors:  Aileen Rivell; Mark P Mattson
Journal:  Trends Neurosci       Date:  2019-09-05       Impact factor: 13.837

Review 6.  Early-onset colorectal cancer: initial clues and current views.

Authors:  Lorne J Hofseth; James R Hebert; Anindya Chanda; Hexin Chen; Bryan L Love; Maria M Pena; E Angela Murphy; Mathew Sajish; Amit Sheth; Phillip J Buckhaults; Franklin G Berger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-21       Impact factor: 46.802

Review 7.  Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.

Authors:  Pau Vancells Lujan; Esther Viñas Esmel; Emilio Sacanella Meseguer
Journal:  Nutrients       Date:  2021-04-24       Impact factor: 5.717

8.  Synergistic effects of fructose and glucose on lipoprotein risk factors for cardiovascular disease in young adults.

Authors:  Bettina Hieronimus; Valentina Medici; Andrew A Bremer; Vivien Lee; Marinelle V Nunez; Desiree M Sigala; Nancy L Keim; Peter J Havel; Kimber L Stanhope
Journal:  Metabolism       Date:  2020-09-09       Impact factor: 8.694

9.  Carbohydrates to Prevent and Treat Obesity in a Murine Model of Diet-Induced Obesity.

Authors:  Ellen Vercalsteren; Christine Vranckx; Katrien Corbeels; Bart Van der Schueren; Greetje Vande Velde; Roger Lijnen; Ilse Scroyen
Journal:  Obes Facts       Date:  2021-07-20       Impact factor: 3.942

Review 10.  NAFLD and cardiovascular diseases: a clinical review.

Authors:  Philipp Kasper; Anna Martin; Sonja Lang; Fabian Kütting; Tobias Goeser; Münevver Demir; Hans-Michael Steffen
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.